1. Home
  2. SRPT vs ICUCW Comparison

SRPT vs ICUCW Comparison

Compare SRPT & ICUCW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • ICUCW
  • Stock Information
  • Founded
  • SRPT 1980
  • ICUCW N/A
  • Country
  • SRPT United States
  • ICUCW United States
  • Employees
  • SRPT N/A
  • ICUCW 12
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • ICUCW Biotechnology: Pharmaceutical Preparations
  • Sector
  • SRPT Health Care
  • ICUCW Health Care
  • Exchange
  • SRPT Nasdaq
  • ICUCW Nasdaq
  • Market Cap
  • SRPT N/A
  • ICUCW N/A
  • IPO Year
  • SRPT 1997
  • ICUCW 2021
  • Fundamental
  • Price
  • SRPT $107.95
  • ICUCW $0.03
  • Analyst Decision
  • SRPT Buy
  • ICUCW
  • Analyst Count
  • SRPT 22
  • ICUCW 0
  • Target Price
  • SRPT $174.64
  • ICUCW N/A
  • AVG Volume (30 Days)
  • SRPT 799.4K
  • ICUCW N/A
  • Earning Date
  • SRPT 02-26-2025
  • ICUCW N/A
  • Dividend Yield
  • SRPT N/A
  • ICUCW N/A
  • EPS Growth
  • SRPT N/A
  • ICUCW N/A
  • EPS
  • SRPT 1.22
  • ICUCW N/A
  • Revenue
  • SRPT $1,640,348,000.00
  • ICUCW N/A
  • Revenue This Year
  • SRPT $53.06
  • ICUCW N/A
  • Revenue Next Year
  • SRPT $68.79
  • ICUCW N/A
  • P/E Ratio
  • SRPT $88.50
  • ICUCW N/A
  • Revenue Growth
  • SRPT 48.45
  • ICUCW N/A
  • 52 Week Low
  • SRPT $102.16
  • ICUCW N/A
  • 52 Week High
  • SRPT $173.25
  • ICUCW N/A
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 33.84
  • ICUCW N/A
  • Support Level
  • SRPT $109.52
  • ICUCW N/A
  • Resistance Level
  • SRPT $114.41
  • ICUCW N/A
  • Average True Range (ATR)
  • SRPT 3.36
  • ICUCW 0.00
  • MACD
  • SRPT -0.50
  • ICUCW 0.00
  • Stochastic Oscillator
  • SRPT 2.73
  • ICUCW 0.00

About ICUCW SeaStar Medical Holding Corporation Warrant

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.

Share on Social Networks: